Search research articles
Contact Us
Filters
Showing results (81-90 of 139) with videos related to
Page
of 14
Sort By:
Diabetes, Obesity & Metabolism
|
March 25, 2026
Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial
Filip K Knop, George Kunos, Dror Dicker, et al.
Advances in Therapy
|
August 19, 2025
Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study
Esther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
Diabetes, Obesity & Metabolism
|
September 13, 2021
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Sean Wharton, Salvatore Calanna, Melanie Davies, et al.
The New England Journal of Medicine
|
April 13, 2022
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Ori Magen, Jacob G Waxman, Maya Makov-Assif, et al.
European Journal of Internal Medicine
|
December 14, 2021
Pulmonary embolism - An EFIM guideline critical appraisal and adaptation for practicing clinicians
Cecilia Becattini, Valentin A Kokorin, Wiktoria Lesniak, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2026
Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials
Matteo Monami, Amanda Belluzzi, Silvio Buscemi, et al.
Obesity Facts
|
April 29, 2021
Vaccinating People with Obesity for COVID-19: EASO Call for Action
Dror Dicker, Rachel Golan, Jennifer Lyn Baker, et al.
Nature Medicine
|
October 2, 2025
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
Barbara McGowan, Andreea Ciudin, Jennifer L Baker, et al.
Nature Medicine
|
October 2, 2025
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO)
Barbara McGowan, Andreea Ciudin, Jennifer L Baker, et al.
Obesity (Silver Spring, Md.)
|
May 23, 2020
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F Kushner, Salvatore Calanna, Melanie Davies, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 139) with videos related to
Sort By:
Page
of 14
Diabetes, Obesity & Metabolism
|
March 25, 2026
Monlunabant in adults with obesity and metabolic syndrome: Open-label extension of a phase 2a trial
Filip K Knop, George Kunos, Dror Dicker, et al.
Advances in Therapy
|
August 19, 2025
Epidemiology Landscape and Impact of Overweight and Obesity in Adults: Multi-country Results from the IMPACT-O Study
Esther Artime, Erik Spaepen, Sarah Zimner-Rapuch, et al.
Diabetes, Obesity & Metabolism
|
September 13, 2021
Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Sean Wharton, Salvatore Calanna, Melanie Davies, et al.
The New England Journal of Medicine
|
April 13, 2022
Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Ori Magen, Jacob G Waxman, Maya Makov-Assif, et al.
European Journal of Internal Medicine
|
December 14, 2021
Pulmonary embolism - An EFIM guideline critical appraisal and adaptation for practicing clinicians
Cecilia Becattini, Valentin A Kokorin, Wiktoria Lesniak, et al.
Diabetes, Obesity & Metabolism
|
March 10, 2026
Weight Loss as a Determinant of Histological Improvement in Metabolic Dysfunction-Associated Steatotic Liver Disease in People With Obesity. A Systematic Review and Network Meta-Analysis of Randomised Clinical Trials
Matteo Monami, Amanda Belluzzi, Silvio Buscemi, et al.
Obesity Facts
|
April 29, 2021
Vaccinating People with Obesity for COVID-19: EASO Call for Action
Dror Dicker, Rachel Golan, Jennifer Lyn Baker, et al.
Nature Medicine
|
October 2, 2025
A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults
Barbara McGowan, Andreea Ciudin, Jennifer L Baker, et al.
Nature Medicine
|
October 2, 2025
Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO)
Barbara McGowan, Andreea Ciudin, Jennifer L Baker, et al.
Obesity (Silver Spring, Md.)
|
May 23, 2020
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5
Robert F Kushner, Salvatore Calanna, Melanie Davies, et al.
Page
of 14